다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Indian journal of microbiology, v.57 no.3, 2017년, pp.359 - 364
Rishi, Lavanya , Mittal, Garima , Agarwal, Rajeev Kumar , Sharma, Taruna
초록이 없습니다.
Microbiology S Vesterlund 152 1819 2006 10.1099/mic.0.28522-0 Vesterlund S, Karp M, Salminen S, Ouwehand AC (2006) Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology 152:1819-1826. doi: 10.1099/mic.0.28522-0
N Engl J Med FD Lowy 339 520 1998 10.1056/NEJM199808203390806 Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532. doi: 10.1056/NEJM199808203390806
J Clin Diagn Res A Kali 7 1979 2013 10.7860/JCDR/2013/6142.3377 Kali A, Stephen S, Umadevi S, Kumar S, Joseph NM, Srirangaraj S (2013) Changing trends in resistance pattern of methicillin resistant Staphylococcus aureus. J Clin Diagn Res 7:1979-1982. doi: 10.7860/JCDR/2013/6142.3377
Indian J Microbiol VC Kalia 54 1 2014 10.1007/s12088-013-0443-7 Kalia VC (2014) Microbes, antimicrobials and resistance: the battle goes on. Indian J Microbiol 54:1-2. doi: 10.1007/s12088-013-0443-7
Trials SYC Tong 17 170 2016 10.1186/s13063-016-1295-3 Tong SYC, Nelson J, Paterson DL et al (2016) CAMERA2-combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials 17:170. doi: 10.1186/s13063-016-1295-3
Indian J Microbiol AP Singh 54 323 2014 10.1007/s12088-014-0463-y Singh AP, Prabha V, Rishi P (2014) Efficacy of cryptdin-2 as an adjunct to antibiotics from various generations against Salmonella. Indian J Microbiol 54:323-328. doi: 10.1007/s12088-014-0463-y
Gut E Isolauri 50 iii54 2002 10.1136/gut.50.suppl_3.iii54 Isolauri E, Kirjavainen PV, Salminen S (2002) Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50:iii54-iii59. doi: 10.1136/gut.50.suppl_3.iii54
Int J Antimicrob Agents H Sikorska 42 475 2013 10.1016/j.ijantimicag.2013.08.003 Sikorska H, Smoragiewicz W (2013) Role of probiotics in the prevention and treatment of methicillin resistant Staphylococcus aureus infections. Int J Antimicrob Agents 42:475-481. doi: 10.1016/j.ijantimicag.2013.08.003
Contemp Clin Trials S Eggers 52 39 2017 10.1016/j.cct.2016.11.004 Eggers S, Barker A, Valentine S, Hess T, Duster M, Safdar N (2017) Impact of probiotics for reducing infections in veterans (IMPROVE): study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus. Contemp Clin Trials 52:39-45. doi: 10.1016/j.cct.2016.11.004
Probiotics Antimicrob Proteins S Kaur 7 172 2015 10.1007/s12602-015-9188-4 Kaur S, Sharma P (2015) Protease-sensitive inhibitory activity of cell-free supernatant of Lactobacillus crispatus 156 synergizes with ciprofloxacin, moxifloxacin and streptomycin against Pseudomonas aeruginosa: an in vitro study. Probiotics Antimicrob Proteins 7:172-180. doi: 10.1007/s12602-015-9188-4
Pathog Dis MS Kang 75 ftx009 2017 10.1093/femspd/ftx009 Kang MS, Lim HS, Oh JS, Lim YJ, Wuertz-Kozak K, Harro JM, Achermann Y (2017) Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus. Pathog Dis 75:ftx009. doi: 10.1093/femspd/ftx009
Can J Infect Dis Med Microbiol M Goetghebeur 18 27 2007 10.1155/2007/253947 Goetghebeur M, Landry PA, Han D, Vicente C (2007) Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences. Can J Infect Dis Med Microbiol 18:27-34
J Clin Invest FD Lowy 111 1265 2003 10.1172/JCI18535 Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265-1273. doi: 10.1172/JCI18535
Drugs GP Wormser 24 459 1982 10.2165/00003495-198224060-00002 Wormser GP, Keusch GT, Heel RC (1982) Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs 24:459-518
J Infect Dis FE Hahn 119 364 1969 10.1093/infdis/119.4-5.364 Hahn FE, Sarre SG (1969) Mechanism of action of gentamicin. J Infect Dis 119:364-369
Pharmacotherapy M LeBel 8 3 1988 10.1002/j.1875-9114.1988.tb04058.x LeBel M (1988) Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 8:3-33
FEMS Microbiol Rev ER Kashket 3 233 1987 10.1111/j.1574-6968.1987.tb02463.x Kashket ER (1987) Bioenergetics of lactic acid bacteria: cytoplasmic pH and osmotolerance. FEMS Microbiol Rev 3:233-244. doi: 10.1111/j.1574-6968.1987.tb02463.x
Syst Appl Microbiol D Haller 24 218 2001 10.1078/0723-2020-00023 Haller D, Colbus H, Gänzle MG, Scherenbacher P, Bode C, Hammes WP (2001) Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and fermented food origin. Syst Appl Microbiol 24:218-226. doi: 10.1078/0723-2020-00023
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.